We are live on ! Find out more
DC

Diametric Capital Portfolio holdings

AUM $385M
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
AUM
$198M
AUM Growth
+$62.8M
Cap. Flow
+$67.4M
Cap. Flow %
33.97%
Top 10 Hldgs %
19.48%
Holding
401
New
131
Increased
80
Reduced
37
Closed
153

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$2.02M
2
OVV icon
Ovintiv
OVV
+$1.2M
3
ELV icon
Elevance Health
ELV
+$1.18M
4
QGEN icon
Qiagen
QGEN
+$1.18M
5
PLAY icon
Dave & Buster's
PLAY
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 26.42%
2 Consumer Discretionary 18.87%
3 Industrials 14.33%
4 Technology 11.45%
5 Energy 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVLR
26
DELISTED
Avalara, Inc.
AVLR
$1.6M 0.81%
+17,409
New +$1.56M
TGNA
27
DELISTED
TEGNA Inc
TGNA
$1.52M 0.77%
73,673
+38,673
+110% +$819K
IEX icon
28
IDEX
IEX
$16.5B
$1.51M 0.76%
+7,555
New +$1.53M
EVOP
29
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$1.51M 0.76%
+45,274
New +$1.4M
ADPT icon
30
Adaptive Biotechnologies
ADPT
$3.56B
$1.49M 0.75%
209,438
+32,316
+18% +$304K
WLK icon
31
Westlake Corp
WLK
$9.46B
$1.48M 0.75%
17,029
+14,817
+670% +$1.42M
Y
32
DELISTED
Alleghany Corp
Y
$1.46M 0.74%
1,741
+741
+74% +$622K
NDSN icon
33
Nordson
NDSN
$16.5B
$1.4M 0.7%
+6,579
New +$1.47M
PACB icon
34
Pacific Biosciences
PACB
$422M
$1.36M 0.69%
+234,707
New +$1.35M
SAGE
35
DELISTED
Sage Therapeutics
SAGE
$1.35M 0.68%
34,515
+15,122
+78% +$585K
META icon
36
Meta Platforms (Facebook)
META
$1.51T
$1.35M 0.68%
9,931
+2,050
+26% +$332K
VMW
37
DELISTED
VMware, Inc
VMW
$1.34M 0.68%
12,589
+8,082
+179% +$931K
XYL icon
38
Xylem
XYL
$28.5B
$1.33M 0.67%
+15,272
New +$1.39M
TXNM
39
TXNM Energy Inc
TXNM
$6.47B
$1.33M 0.67%
+29,023
New +$1.38M
TWNK
40
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$1.32M 0.67%
56,861
+15,194
+36% +$345K
BKI
41
DELISTED
Black Knight, Inc. Common Stock
BKI
$1.29M 0.65%
19,975
+6,975
+54% +$459K
STOR
42
DELISTED
STORE Capital Corporation
STOR
$1.29M 0.65%
+41,184
New +$1.17M
GH icon
43
Guardant Health
GH
$19.5B
$1.27M 0.64%
23,557
+5,003
+27% +$257K
TWTR
44
DELISTED
Twitter, Inc.
TWTR
$1.27M 0.64%
28,921
+16,819
+139% +$685K
TT icon
45
Trane Technologies
TT
$106B
$1.23M 0.62%
8,506
+4,501
+112% +$673K
HUBB icon
46
Hubbell
HUBB
$25.7B
$1.21M 0.61%
+5,424
New +$1.14M
ASH icon
47
Ashland
ASH
$3.04B
$1.21M 0.61%
+12,734
New +$1.3M
CIVI
48
DELISTED
Civitas Resources
CIVI
$1.21M 0.61%
21,035
+11,450
+119% +$674K
FBC
49
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.2M 0.61%
35,928
+14,587
+68% +$557K
LHCG
50
DELISTED
LHC Group LLC
LHCG
$1.19M 0.6%
7,267
+1,267
+21% +$205K

Similar funds

Diametric Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Diametric Capital held 401 positions worth $198M, up 46% from $136M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Diametric Capital deployed $67.4M of net new capital in Q3 2022, opening 131 new positions and adding to 80 existing holdings. Its largest new stake was Bristol-Myers Squibb: 37,584 shares worth $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Dave & Buster's, an estimated $1.12M trimmed.

  • Diametric Capital's largest Q3 2022 buy was Bristol-Myers Squibb: 37,584 shares worth $2.67M.
  • Diametric Capital added most to Boyd Gaming in Q3 2022, an estimated $2.14M increase.
  • Diametric Capital's biggest Q3 2022 reduction was Dave & Buster's, cutting an estimated $1.12M.
  • Diametric Capital fully exited DexCom in Q3 2022, selling an estimated $2.02M.
  • Diametric Capital's ten largest holdings make up 19% of its $198M portfolio in Q3 2022.
  • Diametric Capital opened 131 new positions and closed 153 in Q3 2022.
  • Diametric Capital's portfolio value rose 46% quarter-over-quarter to $198M.

Based on Diametric Capital's 13F filing for Q3 2022, filed 14 Nov 2022.